Indications and Purposes
| 1 Indications And Usage Bendeka Injection Is An Alkylating Drug Indicated For Treatment Of Patients With: Chronic Lymphocytic Leukemia (Cll). Efficacy Relative To First Line Therapies Other Than Chlorambucil Has Not Been Established. ( 1.1 ) Indolent B-Cell Non-Hodgkin Lymphoma (Nhl) That Has Progressed During Or Within Six Months Of Treatment With Rituximab Or A Rituximab-Containing Regimen. ( 1.2 ) 1.1 Chronic Lymphocytic Leukemia (Cll) Bendeka ® Is Indicated For The Treatment Of Patients With Chronic Lymphocytic Leukemia. Efficacy Relative To First Line Therapies Other Than Chlorambucil Has Not Been Established. 1.2 Non-Hodgkin Lymphoma (Nhl) Bendeka Is Indicated For The Treatment Of Patients With Indolent B-Cell Non-Hodgkin Lymphoma That Has Progressed During Or Within Six Months Of Treatment With Rituximab Or A Rituximab-Containing Regimen. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Bendamustine Hydrochloride |
|
ZINC4214955 |